These data add to a growing body of literature that suggests that
women with early-stage ovarian cancer often receive treatment that is
discordant with evidence-based recommendations . Prior studies
have shown that comprehensive surgical staging is commonly omitted
for women with ovarian cancer . In a study of 4057 early stage
ovarian cancer patients from the Health Care Cost and Utilization
Project, only 53% underwent lymph node sampling . Similar to
population-based studies in the United States and Europe, our findings
demonstrate a lack of adherence to comprehensive surgical staging
guidelines in early-stage ovarian cancer,with the omission of lymphadenectomy
occurring in the majority of patients . Our study
adds to prior analyses by focusing on presumed early-stage disease, a
population in whom surgical staging significantly impacts adjuvant
treatment planning and survival. In our cohort, only 46.3% of women